Table 2 |
||||||||
|
Comparison of HA and control baseline, 30, 90 and 356 days followup. |
||||||||
|
Baseline |
D30 |
D90 |
D356 |
|||||
|
HA |
Control |
HA |
Control |
HA |
Control |
HA |
Control |
|
|
|
||||||||
|
Age (y) |
49 ± 15 |
47 ± 11 |
||||||
|
Male % |
55 |
53 |
||||||
|
Duration of symptoms (m) |
18 ± 17 |
22 ± 18 |
||||||
|
VAS-rest (cm) |
8.5 ± 11.1 |
8.4 ± 1.6 |
2.2 ± 1.2* |
7.1 ± 1.3*@ |
2.5 ± 1.4* |
6.7 ± 1.5*@ |
2.4 ± 1.4* |
7.7 ± 1.3*@ |
|
VAS-grip (cm) |
9.8 ± 1.1 |
9.6 ± 0.4 |
2.0 ± 1.5* |
9.9 ± 1.3*@ |
2.2 ± 1.8* |
9.3 ± 1.4*@ |
2.9 ± 1.4* |
9.1 ± 1.1*@ |
|
PGS |
0.3 ± 1.1 |
0.4 ± 1.1 |
4.6 ± 1.4* |
1.6 ± 2.2*@ |
4.8 ± 0.6* |
1.9 ± 0.3*@ |
4.8 ± 0.9* |
1.1 ± 1.8*@ |
|
Grip (PSI) |
49.2 ± 1.1 |
47.9 ± 0.4 |
68.0 ± 2.1 |
45.5 ± 1.1*@ |
67.7 ± 3.0* |
48.1 ± 2.3*@ |
65.7 ± 1.8* |
45.6 ± 1.3*@ |
|
PANF |
1.1 ± 2.1 |
1.7 ± 2.2 |
4.4 ± 0.2* |
2.6 ± 0.4@ |
4.8 ± 0.1* |
1.3 ± 0.7*@ |
4.6 ± 0.3* |
0.9 ± 1.9*@ |
|
PGA |
1.1 ± 1.0 |
0.9 ± 1.2 |
4.3 ± 1.1* |
1.8 ± 2.2*@ |
4.6 ± 1.1* |
2.0 ± 1.7*@ |
4.7 ± 0.5* |
1.3 ± 0.7*@ |
|
AE (N) |
3 |
5 |
||||||
|
|
||||||||
|
VAS-pain are scored as a 100 mm VAS (0 = no pain; 100 = worse pain ever); grip strength (conducted with the patient's elbow fully extended and the dynamometer's handle in the middle position. Patients will perform three grip tests on the affected arm with a mean score calculated and used for analysis--measure in kg); PGS is patient global satisfaction using a 5 point categorical scale (0 = not satisfied, 5 = fully satisfied); PANF is patient assessment of normal function using a 5 point categorical scale (0 = no return to normal function, 5 = full return to normal function); PGA is physician's global assessment of elbow injury using a 5 point categorical scale (0 = poor patient elbow function and poor pain management, 5 = normal patient elbow function and normal pain management); AE are adverse events reported. * = p < 0.05 (within groups); @ = p < 0.05 (between groups) |
||||||||
|
Petrella et al. Sports Medicine, Arthroscopy, Rehabilitation, Therapy & Technology 2010 2:4 doi:10.1186/1758-2555-2-4 |
||||||||